Literature DB >> 6420833

Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.

B A Shaywitz, M H Teicher, D J Cohen, G M Anderson, J G Young, P Levitt.   

Abstract

The relative contribution of dopamine (DA) and norepinephrine (NE) in behavioral arousal was examined in developing rat pups using intracisternal 6-hydroxydopamine (6-OHDA) either alone or following pretreatment with desmethylimipramine (DMI). Such treatments were designed to examine the effects of preferential reduction of DA (DA depletion), NE (NE depletion), or both catecholamines (CA depletion) in the development of motor activity and escape performance. General motor activity increased with age and, over all ages, DA-depleted pups tended to exhibit greater activity. This was most apparent at 15 days of age, where DA-depleted pups were significantly more active than controls, NE-depleted, or CA-depleted pups. DA-depleted pups failed to exhibit the steep decline in activity over time (habituation of activity) demonstrated by the control and NE-depleted pups, while pups depleted of both CA fell into an intermediate position in habituation. Escape latency in a T-maze at 20 days and shuttle box at 26 days of age indicated comparable performance to controls for NE-depleted pups, while those animals in DA-depleted and CA-depleted groups appeared unable to perform the task. Brain CA concentrations (determined by a radioenzymatic assay) indicated preferential reduction of DA in the DA-depleted group to concentrations 25% of controls, reduction of NE to 62% of controls in the NE-depleted group, and reductions of DA to 42% and NE to 60% in the CA-depleted group. These results suggest that preferential reduction of brain DA in the developing rat pup increases motor activity and impairs habituation of activity during the stage of behavioral arousal in week 3 of postnatal life.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420833     DOI: 10.1007/bf00426384

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Effect of various 6-hydroxydopamine treatments during development on growth and ingestive behavior.

Authors:  G R Breese; R D Smith; B R Cooper
Journal:  Pharmacol Biochem Behav       Date:  1975 Nov-Dec       Impact factor: 3.533

2.  Enzymatic O-methylation of epinephrine and other catechols.

Authors:  J AXELROD; R TOMCHICK
Journal:  J Biol Chem       Date:  1958-09       Impact factor: 5.157

3.  The role of catecholamines in behavioral arousal during ontogenesis.

Authors:  B A Campbell; P D Mabry
Journal:  Psychopharmacologia       Date:  1973-07-19

4.  Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?

Authors:  B Costall; D H Fortune; S C Hui; R J Naylor
Journal:  Eur J Pharmacol       Date:  1980-05-16       Impact factor: 4.432

5.  Effect of phenobarbital on activity and learning in 6-hydroxydopamine treated rat pups.

Authors:  B A Shaywitz; D A Pearson
Journal:  Pharmacol Biochem Behav       Date:  1978-08       Impact factor: 3.533

6.  Catecholamines in fetal and newborn rat brain.

Authors:  J T Coyle; D Henry
Journal:  J Neurochem       Date:  1973-07       Impact factor: 5.372

7.  Neurochemical and behavioral evidence for a selective presynaptic dopamine receptor agonist.

Authors:  D P Goodale; D B Rusterholz; J P Long; J R Flynn; B Walsh; J G Cannon; T Lee
Journal:  Science       Date:  1980-12-05       Impact factor: 47.728

8.  Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine.

Authors:  J Glowinski; J Axelrod; L L Iversen
Journal:  J Pharmacol Exp Ther       Date:  1966-07       Impact factor: 4.030

9.  Changes in the behavioral response to a novel environment following lesioning of the central dopaminergic system in rat pups.

Authors:  J C Stoof; H Duijkstra; J P Hillegers
Journal:  Psychopharmacology (Berl)       Date:  1978-04-28       Impact factor: 4.530

10.  Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine.

Authors:  G R Breese; T D Traylor
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

View more
  3 in total

1.  Transgenic mice bearing a human mutant thyroid hormone beta 1 receptor manifest thyroid function anomalies, weight reduction, and hyperactivity.

Authors:  R Wong; V V Vasilyev; Y T Ting; D I Kutler; M C Willingham; B D Weintraub; S Cheng
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

2.  Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial.

Authors:  Rozita Davari-Ashtiani; Mahin Eslami Shahrbabaki; Katayoon Razjouyan; Homayoun Amini; Homa Mazhabdar
Journal:  Child Psychiatry Hum Dev       Date:  2010-12

3.  Effect of neonatal nomifensine exposure on adult behavior and brain monoamines in rats.

Authors:  L A Hilakivi; I Hilakivi; L Ahtee; H Haikala; M Attila
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.